Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Pain Management
  4. Modulation of Aryl Hydrocarbon Receptor Expression Alleviated Neuropathic Pain in a Chronic Constriction Nerve Injury Animal Model

Modulation of Aryl Hydrocarbon Receptor Expression Alleviated Neuropathic Pain in a Chronic Constriction Nerve Injury Animal Model

Int. J. Mol. Sci., 2022 · DOI: 10.3390/ijms231911255 · Published: September 24, 2022

Pain ManagementGenetics

Simple Explanation

Neuropathic pain, a persistent condition resulting from somatosensory system damage, affects a significant portion of the population and responds poorly to common analgesics. This study investigates the role of the Aryl hydrocarbon receptor (AhR) in regulating neuropathic pain using nerve explant culture and a chronic constrictive nerve injury (CCI) model in mice. The study found that AhR deletion worsened nerve damage and inflammation, while the AhR agonist omeprazole attenuated these effects. This suggests that AhR agonists could be potential candidates for treating neuropathic pain. Researchers used nerve explants from wild-type and AhR-knockout mice to examine omeprazole's ability to prevent nerve degeneration. They also subjected both types of mice to chronic constrictive nerve injury, treating some with omeprazole, and then analyzed neurobehavior and tissues.

Study Duration
Not specified
Participants
Wild-type and AhR-knockout mice
Evidence Level
Level 5, Animal Model

Key Findings

  • 1
    Deletion of AhR aggravated nerve damages and this was restored by omeprazole, indicating a protective role of AhR in nerve health.
  • 2
    High expression of AhR in the injured nerve was noted after CCI, suggesting that AhR is involved in the response to nerve injury.
  • 3
    Omeprazole interacts with the AhR site (Ser36). In the nerve explant culture or CCI model, AhR deletion aggravated nerve degeneration, while AhR restored the nerve damage.

Research Summary

This study investigates the role of AhR in neuropathic pain using nerve explant cultures and a CCI model in mice. The findings suggest that AhR agonists could be potential candidates for neuropathic pain treatment. The principal finding is that the modulation of AhR appeared to play a significant role for the development in neuropathic pain. The deletion of AhR significantly contributed to the occurrence of neuropathic pain while AhR agonist counteracted such an effect. Chronic constrictive nerve injury augmented AhR expression of the injured nerve, and AhR deletion worsened the damage, while AhR agonist omeprazole counteracted such changes.

Practical Implications

Therapeutic potential of AhR agonists

AhR agonists like omeprazole may offer a new approach for treating neuropathic pain.

Understanding AhR's role

Further research into AhR's mechanisms in nerve injury could lead to more targeted therapies.

Clinical applications

The study supports clinical trials to evaluate the efficacy of AhR agonists in patients with neuropathic pain.

Study Limitations

  • 1
    The spatial and temporal effects of microglia affected by AhR were not assessed.
  • 2
    Limited generalizability due to the use of an animal model.
  • 3
    Not specified

Your Feedback

Was this summary helpful?

Back to Pain Management